ResultsBusiness Standard
Symbiotec Pharma shares hit new high on Q2 results
Positive+23Company event
GreyOak summary
Symbiotec Pharmalab shares surged 20% to a new high of ₹1,525.80 following Q2 FY27 results showing a 169% PAT jump to ₹52 crore. The rally was also driven by a 10-year contract win for manufacturing alternative protein with a European partner.
What it affects
- Symbiotec PharmalabSYMBIOTECPositive +23
Shares rose 20% on Q2 resultsRolling sentiment Positive +29
Source
Read the original at Business StandardMore Symbiotec Pharmalab news
- Motilal Oswal raises Symbiotec target to Rs 1800Moneycontrol · Company update ·
- Pharma stocks rally: Aurobindo, Divi's, Glenmark, Symbiotec hit new highsBusiness Standard · Stock view ·